Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Ten fingers not needed for fast typing

  • Companies must adapt internal communication as demographics change, study finds

  • Common gene variant influences food choices ... for better or worse

  • Americans recognize 'past presidents' who never were, study finds

  • New guideline for treatment of prolonged seizures in children and adults

  • It doesn't 'get better' for some bullied LGBT youths

  • Does shopping help you feel better after a setback?

  • Find a partner who marches to the beat of your own drum

  • COPD may cause structural changes within the brain

  • Stereotypes about Native Americans and alcohol debunked

  •